204 related articles for article (PubMed ID: 21766476)
1. Competition by inhibitory oligonucleotides prevents binding of CpG to C-terminal TLR9.
Avalos AM; Ploegh HL
Eur J Immunol; 2011 Oct; 41(10):2820-7. PubMed ID: 21766476
[TBL] [Abstract][Full Text] [Related]
2. New vistas on TLR9 activation.
Wagner H
Eur J Immunol; 2011 Oct; 41(10):2814-6. PubMed ID: 21953639
[TBL] [Abstract][Full Text] [Related]
3. Single Stranded DNA Immune Modulators with Unmethylated CpG Motifs: Structure and Molecular Recognition by Toll-Like Receptor 9.
Fehér K
Curr Protein Pept Sci; 2019; 20(11):1060-1068. PubMed ID: 31470785
[TBL] [Abstract][Full Text] [Related]
4. Species-Specific Minimal Sequence Motif for Oligodeoxyribonucleotides Activating Mouse TLR9.
Pohar J; Lainšček D; Fukui R; Yamamoto C; Miyake K; Jerala R; Benčina M
J Immunol; 2015 Nov; 195(9):4396-405. PubMed ID: 26416273
[TBL] [Abstract][Full Text] [Related]
5. Selectivity of Human TLR9 for Double CpG Motifs and Implications for the Recognition of Genomic DNA.
Pohar J; Yamamoto C; Fukui R; Cajnko MM; Miyake K; Jerala R; Benčina M
J Immunol; 2017 Mar; 198(5):2093-2104. PubMed ID: 28115525
[TBL] [Abstract][Full Text] [Related]
6. Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cells.
Römmler F; Hammel M; Waldhuber A; Müller T; Jurk M; Uhlmann E; Wagner H; Vollmer J; Miethke T
PLoS One; 2015; 10(2):e0116703. PubMed ID: 25695778
[TBL] [Abstract][Full Text] [Related]
7. Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction.
Suwarti S; Yamazaki T; Svetlana C; Hanagata N
Biochem Biophys Res Commun; 2013 Jan; 430(4):1234-9. PubMed ID: 23266611
[TBL] [Abstract][Full Text] [Related]
8. Necessity of oligonucleotide aggregation for toll-like receptor 9 activation.
Wu CC; Lee J; Raz E; Corr M; Carson DA
J Biol Chem; 2004 Aug; 279(32):33071-8. PubMed ID: 15184382
[TBL] [Abstract][Full Text] [Related]
9. Minimal sequence requirements for oligodeoxyribonucleotides activating human TLR9.
Pohar J; Kužnik Krajnik A; Jerala R; Benčina M
J Immunol; 2015 Apr; 194(8):3901-8. PubMed ID: 25780037
[TBL] [Abstract][Full Text] [Related]
10. Granulin is a soluble cofactor for toll-like receptor 9 signaling.
Park B; Buti L; Lee S; Matsuwaki T; Spooner E; Brinkmann MM; Nishihara M; Ploegh HL
Immunity; 2011 Apr; 34(4):505-13. PubMed ID: 21497117
[TBL] [Abstract][Full Text] [Related]
11. CpG oligonucleotides bind TLR9 and RRM-containing proteins in Atlantic salmon (Salmo salar).
Iliev DB; Skjæveland I; Jørgensen JB
BMC Immunol; 2013 Mar; 14():12. PubMed ID: 23452377
[TBL] [Abstract][Full Text] [Related]
12. Involvement of DNA-PKcs in the type I IFN response to CpG-ODNs in conventional dendritic cells in TLR9-dependent or -independent manners.
Ma C; Spies NP; Gong T; Jones CX; Chu WM
PLoS One; 2015; 10(3):e0121371. PubMed ID: 25812014
[TBL] [Abstract][Full Text] [Related]
13. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
[TBL] [Abstract][Full Text] [Related]
14. Phosphorothioate-modified TLR9 ligands protect cancer cells against TRAIL-induced apoptosis.
Chiron D; Pellat-Deceunynck C; Maillasson M; Bataille R; Jego G
J Immunol; 2009 Oct; 183(7):4371-7. PubMed ID: 19734228
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9.
Pohar J; Lainšček D; Kunšek A; Cajnko MM; Jerala R; Benčina M
Sci Rep; 2017 Nov; 7(1):14598. PubMed ID: 29097808
[TBL] [Abstract][Full Text] [Related]
16. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
Lai CY; Yu GY; Luo Y; Xiang R; Chuang TH
Front Immunol; 2019; 10():179. PubMed ID: 30800129
[TBL] [Abstract][Full Text] [Related]
17. CpG and non-CpG oligodeoxynucleotides directly costimulate mouse and human CD4+ T cells through a TLR9- and MyD88-independent mechanism.
Landrigan A; Wong MT; Utz PJ
J Immunol; 2011 Sep; 187(6):3033-43. PubMed ID: 21844387
[TBL] [Abstract][Full Text] [Related]
18. Mannose receptor 1 mediates cellular uptake and endosomal delivery of CpG-motif containing oligodeoxynucleotides.
Moseman AP; Moseman EA; Schworer S; Smirnova I; Volkova T; von Andrian U; Poltorak A
J Immunol; 2013 Dec; 191(11):5615-24. PubMed ID: 24184555
[TBL] [Abstract][Full Text] [Related]
19. Bacterial CpG-DNA aggravates immune complex glomerulonephritis: role of TLR9-mediated expression of chemokines and chemokine receptors.
Anders HJ; Banas B; Linde Y; Weller L; Cohen CD; Kretzler M; Martin S; Vielhauer V; Schlöndorff D; Gröne HJ
J Am Soc Nephrol; 2003 Feb; 14(2):317-26. PubMed ID: 12538732
[TBL] [Abstract][Full Text] [Related]
20. Ligand-induced conformational changes allosterically activate Toll-like receptor 9.
Latz E; Verma A; Visintin A; Gong M; Sirois CM; Klein DC; Monks BG; McKnight CJ; Lamphier MS; Duprex WP; Espevik T; Golenbock DT
Nat Immunol; 2007 Jul; 8(7):772-9. PubMed ID: 17572678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
